507 results on '"Bernardini, Marcus Q."'
Search Results
52. Figure S6 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
53. Supplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
54. Supplementary Tables S1-S3 from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
55. Supplemental Tables from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
56. Disturbed sleep is associated with reduced verbal episodic memory and entorhinal cortex volume in younger middle-aged women with risk-reducing early ovarian removal
57. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
58. Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
59. Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
60. Trends over time in the use of laparoscopic hysterectomy for the treatment of endometrial cancer
61. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer
62. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer
63. Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes
64. Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer
65. Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review
66. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas
67. The prognostic value of perioperative, pre‐systemic therapy CA125 levels in patients with high‐grade serous ovarian cancer
68. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
69. The optimal time for surgery in women with serous ovarian cancer
70. Leiomyosarcoma
71. Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer
72. A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
73. Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci
74. Implementation of a standardized voiding protocol after minimally invasive surgery: A quality improvement initiative
75. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
76. A Triage Assessment Strategy for the Management of Women With Endometrial Cancer
77. Polygenic risk modeling for prediction of epithelial ovarian cancer risk
78. Comparison of three surgical approaches for staging lymphadenectomy in high‐risk endometrial cancer
79. Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?
80. Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer.
81. Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.
82. Extraocular sebaceous carcinoma arising in a mature cystic teratoma of ovary: A case report and review of literature
83. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
84. Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic.
85. Endometrial Cancer: Transitioning from Histology to Genomics
86. Sensor detection in gynaecological medicine
87. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma
88. A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher
89. Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancer
90. The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma
91. Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer
92. The Prevent Ovarian Cancer Program (POCP): Identification of Women at Risk for Ovarian Cancer Using Complementary Recruitment Approaches
93. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing
94. Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer
95. Providers’ perspectives on reproductive decision-making amongst patients carrying a BRCA mutation: a needs assessment
96. Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls
97. Cognitive markers of dementia risk in middle-aged women with bilateral salpingo-oophorectomy prior to menopause
98. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non- serous, non-mucinous ovarian cancers.
99. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
100. Recurrent chromosomal translocations in sarcomas create a mega-complex that mislocalizes NuA4/TIP60 to Polycomb target loci
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.